Humana (HUM) PT Lowered to $290 at BMO Capital on 3Q Report; 'Increased Competition in Medicare'
Tweet Send to a Friend
BMO Capital lowered its price target on Humana (NYSE: HUM) to $290.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
